ReviewSkeletal metastases – The role of the orthopaedic and spinal surgeon
Introduction
Metastatic bone disease forms the final common pathway of many malignancies. Bone is the third commonest site of metastases after the lungs and liver. At post mortem 84% of patients with breast or prostate cancer have some form of skeletal deposits [1]. Patients with thyroid, lung and renal cancer have metastases in 50%, 44% and 37% respectively [2].
Although metastatic bone disease (MBD) seldom causes fatalities directly, it often dramatically and deleteriously affects quality of life. As oncological treatments have developed, life expectancy for patients with MBD has improved. Prognosis has been well reported; the median survival following diagnosis of MBD in patients with breast and prostate cancer is more than 2 and 3 years respectively [3], [4]. During this time patients are at significant risk of suffering skeletal related complications. This makes their appropriate management essential.
Advances in the fields of orthopaedic and spinal surgery mean many surgical options are available to treat skeletal metastases. Despite this the general levels of understanding of the role of surgery in MBD remain low. This unfortunately inevitably translates into the delayed or under-referral of patients that may benefit from surgery [5], [6].
This review outlines the role of orthopaedic and spinal surgeons in the management metastatic lesions of the appendicular skeleton and spine. We discuss the general principles of metastatic bone surgery, and some of the prophylactic, reactive and emergency scenarios where referral for consideration of surgery is appropriate. We also discuss the role of imaging, diagnosis and staging preoperatively, and propose which patients should be referred for an orthopaedic or spinal opinion, and those which are unlikely to benefit.
Section snippets
Assessment of patients with skeletal metastases
Patients with MBD typically present to orthopaedic or spinal surgeons acutely (following a pathological fracture or the development of neurological compromise) or semi-electively (for consideration of prophylactic surgical stabilisation.) In both scenarios a detailed assessment should be performed, including a history, examination, appropriate investigations and imaging, and sometimes a biopsy. This allows a definitive diagnosis to be made, and accurate staging to take place that provides
Overview
Surgical management of metastatic bone disease should be approached via a multidisciplinary team. Because patients with MBD may present in several ways, to a wide variety of specialities, a coordinated response with efficient liaison is therefore essential.
The roles of orthopaedic and spinal surgery in the management of metastatic bone disease fall generally into one of three categories: the prophylactic fixation of metastatic deposits at risk of impending fracture (preventative surgery), the
Prophylactic surgery
Referral of patients at risk of fracture for prophylactic surgery results in a reduction of patient morbidity, length of hospital stay and maximises quality of life. Appropriate patient selection is paramount. Patients with slowly growing primary malignancies appear to recover well from prophylactic procedures [28]. In contrast, the presence of visceral, cerebral or multiple skeletal metastases, a poor ECOG status, and the use of previous chemotherapy all reduce survival rate [35]. Accurate
Reactive surgery
Despite evidence that prophylactic surgery is preferential (with prophylactic stabilisation being technically easier and less traumatic for patients), up to one third of patients with skeletal metastases suffer pathological fractures [39]. Metastatic bones are weak, and fractures rarely unite even when stabilised appropriately. In spite of this a good functional outcome can be achieved when surgery is implemented appropriately. Denying surgical treatment should be avoided if at all possible, as
Metastatic disease of the spine
The spine is the commonest site for MBD. Up to 70% of cancer patients develop metastatic disease. Of these, 40% develop spinal metastatic disease, and 10–20% of these will develop metastatic spinal cord compression (MSCC). Compression most commonly affects the thoracic region (70%) followed by the lumbar (20%) and the cervical spine (10%) [40]. Neurological compression occurs either by direct extension of a metastatic deposit or through a pathological fracture or vertebral instability. This
Complications of orthopaedic and spinal surgery
Patients with metastatic bone disease are particularly susceptible to the general risks of surgery and anaesthesia. Pre-operative assessment by an experienced anaesthetist and the availability of high-dependency beds are essential. Complications specific to orthopaedic surgery should also be recognised. Fat Emboli Syndrome (FES) or tumour emboli can follow surgery on the long bones, particularly where the medullary canal has been reamed. Fat microemboli cause pulmonary and cerebral
Summary
Patients with skeletal metastases must be managed appropriately to ensure life expectancy and quality of life are maximised. Early recognition of metastatic bone disease and appropriate referral to an orthopaedic or spinal surgeon is often paramount to enable this. Patients with cancer and symptoms of skeletal metastases should be investigated urgently. Clinicians have many imaging modalities available to them, each with specific indications and advantages.
Definitively diagnosing a skeletal
Key messages
- ■
Management of MBD is the domain of the site specific MDT but each trust should have an orthopaedic lead clinician for MBD
- ■
Bone pain in the cancer patient should be taken seriously and investigated
- ■
Impending fractures are easier to treat than established fractures and the recovery is swifter
- ■
Back pain in the presence of MBD should be regarded as impending spinal cord compression and managed appropriately
- ■
Pain precedes neurological compromise in most cases of MSCC
- ■
Increased awareness of surgical
Conflict of interest statement
None declared.
Funding
No funds were received in support of this study.
Authorship statement
Guarantor of the integrity of the study: Ashford
Study concepts: Ashford
Study design: Eastley/Ashford
Literature research: Eastley
Manuscript preparation: Eastley/Ashford/Newey
Manuscript editing: Eastley/Ashford/Newey
Manuscript review: Eastley/Ashford/Newey
References (45)
Malignant bone pain: pathophysiology and treatment
Pain
(1997)- et al.
The radiological demonstration of osseous metastases: experimental observations
Clin Radiol
(1967) - et al.
Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases
Clin Radiol
(1999) - et al.
Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer
Urology
(1999) Principles of management of metastatic disease
Curr Orthop
(1988)Orthopaedic management of metastatic bone disease
(1988)The management of cancer metastatic to bone
J Am Med Assoc
(1994)- et al.
The clinical course of bone metastases in breast cancer
Br J Cancer
(1987) - et al.
Evaluation of the prognosis of cancer patients with metastatic bone tumors based on serial bone scintigrams
Jpn J Clin Oncol
(1997) - et al.
Spinal instability secondary to metastatic cancer
Curr Concepts Rev J Bone Jt Surg (Am)
(2000)
Orthopaedic management of structurally significant bone disease in breast cancer metastases
Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases
J Nucl Med
Evaluation and skeletal metastases
Br J Radiol
Skeletal metastases and mammary cancer
Ann R Coll Surg Engl
Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care
J Clin Oncol
A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases
Am J Roentgenol
Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system
J Comput Assist Tomogr
Comparison of whole-body MR imaging and bone scintigraphy in the detection of bone metastases from breast cancer
Br J Radiol
Detection of malignant bone tumors: MR imaging vs scintigraphy
AJR Am J Roentgenol
Vertebral metastases and an equivocal bone scan: value of magnetic resonance imaging
Nucl Med Commun
Magnetic resonance imaging in screening for bone metastasis? A prospective comparison with bone scintigraphy
Nuklearmedizin
Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT
Eur Radiol
Cited by (54)
Alternate modalities for palliation
2023, Palliative Radiation OncologyPalliative radiation
2023, Palliative Radiation OncologyAssessment, Treatment, and Rehabilitation of Bone and Spinal Metastasis in Lung Cancer
2022, Lung Cancer RehabilitationUse of endoprostheses for proximal femur metastases results in a rapid rehabilitation and low risk of implant failure A prospective population-based study
2019, Journal of Bone OncologyCitation Excerpt :Treating metastatic bone disease (MBD) is in most cases a matter of preserving quality of life (QoL) for patients at their end of life [1,2].
Metastatic fractures of long limb bones
2017, Orthopaedics and Traumatology: Surgery and Research